Exosomes as drug delivery systems: A brief overview and progress update SM Patil, SS Sawant, NK Kunda European Journal of Pharmaceutics and Biopharmaceutics, 2020 | 160 | 2020 |
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery KC Petkar, SM Patil, SS Chavhan, K Kaneko, KK Sawant, NK Kunda, ... Pharmaceutics 13 (4), 455, 2021 | 85 | 2021 |
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda, K Patel Nanomedicine 16 (14), 1187-1202, 2021 | 82 | 2021 |
Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment SS Sawant, SM Patil, V Gupta, NK Kunda International Journal of Molecular Sciences 21 (20), 7575, 2020 | 69 | 2020 |
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC) SM Patil, SS Sawant, NK Kunda International Journal of Pharmaceutics 607, 121046, 2021 | 57 | 2021 |
Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture SM Patil, NK Kunda Pharmaceutical Research, 1-12, 2022 | 31 | 2022 |
Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation SS Sawant, SM Patil, SK Shukla, NS Kulkarni, V Gupta, NK Kunda Drug Delivery and Translational Research, 1-14, 2021 | 31 | 2021 |
Solubility Enhancement and Inhalation Delivery of Cyclodextrin-Based Inclusion Complex of Delamanid for Pulmonary Tuberculosis Treatment SM Patil, DS Barji, T Chavan, K Patel, AJ Collazo, V Prithipaul, A Muth, ... AAPS PharmSciTech 24 (1), 49, 2023 | 13 | 2023 |
Anticancer activity of D-LAK-120A, an antimicrobial peptide, in non-small cell lung cancer (NSCLC) SM Patil, NK Kunda Biochimie 201, 7-17, 2022 | 12 | 2022 |
Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment SM Patil, DS Barji, S Aziz, DA McChesney, S Bagde, P Muttil, NK Kunda International Journal of Pharmaceutics 634, 122641, 2023 | 8 | 2023 |
A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment SM Patil, AM Diorio, P Kommarajula, NK Kunda International Journal of Pharmaceutics 653, 123920, 2024 | 4 | 2024 |
Pulmonary delivery of bedaquiline-loaded cubosomes for non-small cell lung cancer (NSCLC) treatment SM Patil, SS Sawant, NK Kunda JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A4-A4, 2022 | 3 | 2022 |
Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment DS Rongala, SM Patil, NK Kunda Pharmaceuticals 17 (6), 754, 2024 | 1 | 2024 |
Oral inhalation of dacomitinib nanocarriers as a therapeutic strategy for non-small cell lung cancer DS Rongala, SM Patil, NK Kunda Nanomedicine 19 (18-20), 1601-1613, 2024 | | 2024 |
A QUALITY-BY-DESIGN APPROACH FOR THE DEVELOPMENT OF INHALABLE DRY POWDERS FOR TUBERCULOSIS (TB) TREATMENT SM Patil | | 2024 |
Formulation Development of Inhalable Dacomitinib Polymeric Nanoparticles for Non-Small Cell Lung Cancer Treatment D Barji, SM Patil, NK Kunda JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 35 (2), A18-A19, 2022 | | 2022 |
Development of Inhalable Nisin ZP Dry Powder for Non-small Cell Lung Cancer Treatment SM Patil, DS Barji, NK Kunda JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 33, A37-A40, 2022 | | 2022 |
Aerosolized Nanoliposomal Carrier of Remdesivir (AL-Rem) – A Potential Alternative to the Existing Covid-19 Treatment RV Vartak, SM Patil, AL Saraswat, MP Patki, NK Kunda, KD Patel Respiratory Drug Delivery 2021, 277-281, 2021 | | 2021 |
Formulation Development of Inhalable Osimertinib Liposomes for the Treatment of Non-Small Cell Lung Cancer SS Sawant, SM Patil, NK Kunda Respiratory Drug Delivery 2021, 1-5, 2021 | | 2021 |